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Summary
Background Therapeutic hypothermia is standard of care in high-income countries for babies born with signs of 
hypoxic ischaemic encephalopathy, but optimal feeding during treatment is uncertain and practice is variable. This 
study aimed to assess the association between feeding during therapeutic hypothermia and clinically important 
outcomes.
Methods We did a population-level retrospective cohort study using the UK National Neonatal Research Database. 
We included all babies admitted to National Health Service neonatal units in England, Scotland, and Wales between 
Jan 1, 2010, and Dec 31, 2017, who received therapeutic hypothermia for 72 h or died during this period. For analysis, 
we created matched groups using propensity scores and compared outcomes in babies who were fed versus unfed 
enterally during therapeutic hypothermia. The primary outcome was severe necrotising enterocolitis, either confirmed 
at surgery or causing death. Secondary outcomes include pragmatically defined necrotising enterocolitis (a recorded 
diagnosis of necrotising enterocolitis in babies who received at least 5 consecutive days of antibiotics while also nil by 
mouth during their neonatal unit stay), late-onset infection (pragmatically defined as 5 consecutive days of antibiotic 
treatment commencing after day 3), survival to discharge, measures of breastmilk feeding, and length of stay in 
neonatal unit.
Findings 6030 babies received therapeutic hypothermia, of whom 1873 (31·1%) were fed during treatment. 
Seven (0·1%) babies were diagnosed with severe necrotising enterocolitis and the number was too small for 
further analyses. We selected 3236 (53·7%) babies for the matched feeding analysis (1618 pairs), achieving a 
good balance for all recorded background variables. Pragmatically defined necrotising enterocolitis was rare 
in both groups (incidence 0·5%, 95% CI 0·2–0·9] in the fed group vs 1·1% [0·7–1·4] in the unfed group). The 
enterally fed group had fewer pragmatically defined late-onset infections (difference –11·6% [95% CI –14·0 to –9·3]; 
p<0·0001), higher survival to discharge (5·2% [3·9–6·6]; p<0·0001), higher proportion of breastfeeding at 
discharge (8·0% [5·1–10·8]; p<0·0001), and shorter neonatal unit stays (–2·2 [–3·0 to –1·2] days; p<0·0001) 
compared with the unfed group.
Interpretation Necrotising enterocolitis is rare in babies receiving therapeutic hypothermia. Enteral feeding during 
hypothermia is safe and associated with beneficial outcomes compared with not feeding, although residual confounding 
could not be completely ruled out. Our findings support starting milk feeds during therapeutic hypothermia.
Funding UK National Institute for Health Research Health Technology Assessment programme 16/79/13.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Therapeutic hypothermia is standard of care in high-
income countries for babies born at or after 36 weeks 
of gestational age with signs of hypoxic ischaemic 
encephalopathy.1 Optimal nutritional support for babies 
re ceiving therapeutic hypothermia is un certain; previ-
ously published trials either did not specify nutritional 
management2 or stipulated that milk feeds should be 
withheld.3 In the absence of high-quality evidence, pro-
vision of enteral nutrition to infants during hypothermia 
is variable;4 withholding enteral feeds during therapeutic 
hypothermia is almost universal in some settings,5 
whereas in other settings milk feeding is routine.6
Milk feeds are withheld during therapeutic hypothermia 
partly to reduce the risk of necrotising enterocolitis. The 
incidence of necrotising enterocolitis in term and near 
term infants with neonatal encephalopathy is poorly 
reported but is thought to be low.2,7 Furthermore, some 
data suggest beneficial effects of enteral feeding after 
perinatal ischaemia.8
Given the context of variable clinical practice and a 
paucity of high-quality evidence, we aimed to identify 
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optimal enteral feeding strategies for babies receiving 
therapeutic hypothermia. Because key outcomes, such 
as necrotising enterocolitis, are rare in this population 
of term and near-term babies, a randomised controlled 
trial powered to address such outcomes is not feasible. 
We therefore did an observational study using routinely 
recorded clinical data, and applied propensity-score 
matching to form groups for comparison that had nearly 
identical distributions of background variables.9,10 We 
aimed to assess the association between enteral feeding 
during therapeutic hypothermia and the incidence of 
necrotising enterocolitis and other clinically important 
outcomes.
Methods
Study design and data source
We did a population-level, retrospective cohort study 
using routinely recorded neonatal clinical data held in 
the UK National Neonatal Research Database (NNRD). 
The NNRD11 holds data from all infants (approximately 
90 000 annually) admitted to National Health Service 
(NHS) neonatal units in England, Scotland, and Wales. 
In the UK, therapeutic hypothermia is not provided 
outside of NHS neonatal units. Data held by the NNRD 
are extracted from neonatal electronic health records 
that have been completed by health professionals during 
routine clinical care. The neonatal dataset12 (a defined 
extract of approx imately 450 data items) is transmitted 
quarterly to the Neonatal Data Analysis Unit, in which 
patient episodes across different hospitals are linked 
and the data are cleaned (ie, queries about discrepancies 
and implausible data configurations are fed back to 
health professionals and rectified). The completeness 
and accuracy of data held in the NNRD have been valid-
ated against case-record forms completed as part of a 
multicentre randomised controlled trial.11 NNRD data 
items include demographic and admission items (birth-
weight), daily items (feeding information), dis charge 
items (weight at discharge), and ad-hoc items entered if 
and when they occur (eg, ultrasound scan findings).
The study was designed by a multiprofessional in-
vesti gator group, which included a parent of a baby who 
received therapeutic hypothermia and a parent represen-
tative. Study outcomes were chosen to reflect those 
priori tised as important by parents, patients, and pro-
fessionals,13 and were informed by parents and parent 
representatives. Research ethics approval for the study 
was obtained from East Midlands—Leicester Central 
Research Ethics Committee (17/EM/0307) and approval 
for inclusion of their data in this study was obtained 
from all English, Scottish, and Welsh neonatal units.
The study was prospectively registered (ISRCTN registry 
ISRCTN47404296; ClinicalTrials.gov NCT03278847) and 
the protocol has been published previously.14
Participants
We extracted NNRD data for infants born between 
Jan 1, 2008, and Dec 31, 2017, who were admitted to 
NHS neonatal units in England, Scotland, and Wales 
that contributed data to the NNRD. Neonatal unit data 
from Jan 1, 2008 onwards, is held by the NNRD; from 
Jan 1, 2012 onwards, all NHS neonatal units in England 
and Wales have contributed data. Data were extracted 
for the duration of an infant’s neonatal unit stay.
Infants were eligible for inclusion in the study if they 
had a recorded gestational age of 36 weeks or older at birth 
Research in context
Evidence before this study
We developed this study in 2017 and on July 7, 2017, searched 
PubMed using the search terms “therapeutic hypothermia” 
AND (“enteral” OR “nutrition”) without publication date or 
language restrictions, for articles describing feeding practices 
during neonatal therapeutic hypothermia. In the 11 trials 
included in the Cochrane review of hypothermia for hypoxic 
ischaemic encephalopathy, feeds were either withheld during 
therapeutic hypothermia, or feeding practice was either not 
stipulated or not reported. We found no published randomised 
controlled trials directly addressing this topic. One retrospective 
cohort study of 85 infants receiving therapeutic hypothermia 
compared practice in the UK where a majority of babies were 
not fed, and practice in Sweden where the majority of babies 
received milk feeds, and found no differences in clinical 
outcomes between countries and found no cases of necrotising 
enterocolitis. We repeated the PubMed search on Nov 12, 2020, 
using the same search terms. One retrospective, matched, 
case control study of 34 infants receiving therapeutic 
hypothermia in the USA compared inflammatory markers in 
babies that received minimal enteral nutrition versus babies 
who had feeds withheld, and found lower concentrations of 
inflammatory cytokines and fewer days of parenteral nutrition 
and days of hospital stay in the enteral feeding group. Surveys 
of practice in the UK, the USA, and Europe show that feeding 
practice during therapeutic hypothermia is variable. 
Added value of this study
To our knowledge, our study analysed the largest cohort of babies 
who have received therapeutic hypothermia. Using national, 
population-level observational data, we produced and compared 
incidence data for necrotising enterocolitis, late-onset 
culture-positive bloodstream infection, and other outcomes 
between babies fed enterally versus babies from whom feeds 
were withheld during therapeutic hypothermia. We found that 
necrotising enterocolitis was rare, and enteral feeding during 
hypothermia treatment was safe and might be beneficial. 
Implications of all the available evidence
These results support starting milk feeds in babies during 
therapeutic hypothermia, using maternal milk if available. 
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and were recorded either as having received therapeutic 
hypothermia for 3 days or as having died during that 
period after receipt of therapeutic hypothermia. UK 
national guidance15 during the study period recommended 
giving therapeutic hypothermia to babies with moderate 
to severe hypoxic ischaemic encephalopathy, as diagnosed 
in trials such as TOBY.7
Procedures
We applied propensity-score methods to form matched 
subgroups to compare outcomes of infants with similar 
background characteristics but who had different enteral 
feeding strategies: babies that were enterally fed versus 
not enterally fed during therapeutic hypothermia. Being 
fed was defined as receiving milk feeds of any type, by any 
enteral route of administration, and in any quantity, for at 
least 1 day during the period of therapeutic hypothermia. 
Further details of codes used to define analysis groups are 
available in the appendix (p 2).
Outcomes
The primary outcome was severe necrotising entero-
colitis (using the UK Neonatal Collaborative definition16) 
confirmed at surgery or causing death, validated with 
the neonatal units. Secondary outcomes included prag-
matically defined necrotising enterocolitis (defined as 
a recorded diagnosis of necrotising enterocolitis in 
babies who received at least 5 days consecutively of 
antibiotics while also nil by mouth during their neo-
natal unit stay); culture positive, late-onset blood stream 
infection (defined using the UK National Neonatal 
Audit Programme case definition as a pure growth 
of a pathogen from blood17); suspected late-onset 
infection (defined as 5 days consecutively of antibiotic 
treatment commencing after day 3); survival to dis-
charge from neonatal unit; length of neonatal unit stay; 
hypo glycaemia; breastfeeding at discharge; onset of 
breast feeding (in babies who breast fed); age in days at 
receipt of first maternal milk (in babies that received 
maternal milk); days with a central line; duration of 
parenteral nutrition in days; and weight-for-age SD 
score at neonatal discharge. Further details of outcomes 
are available in the appendix (pp 2–5).
Statistical analysis
The a-priori estimated sample size was 7200 babies, 
which was estimated to detect (two-sided 5% significance, 
power 90%) a difference of 0·7% in necrotising entero-
colitis with 2000 matched pairs, assuming a negligible 
rate of necrotising enterocolitis in the not fed group. 
To address potential confounders (eg, infants with 
multi system disease, who might be more likely to have 
feeds withheld and also to have poorer outcomes than 
babies without multisystem disease), we used propensity 
score matching to form subgroups of infants with similar 
background characteristics (including clinical condition 
and treatment) when therapeutic hypothermia was started. 
The variables in the propensity model included demo-
graphic items (eg, gestational age, weight-for-age SD score, 
sex, birth multiplicity; maternal factors (eg, age, duration 
of rupture of membranes, fever, suspected chorio-
amnionitis, smoking status, ethnicity, deprivation score, 
hypothyroidism, diabetes, mode of delivery of infant, 
parity); factors at birth (eg, Apgar scores at 1 min 
and 5 min, chest compressions administered during 
resuscitation, emergency resuscitation drugs given, intub-
ated at re susci tation, umbilical cord base excess, time 
to first spontaneous breath); condition on admission 
before therapeutic hypo thermia (eg, mean blood pressure, 
glucose, heart rate, oxygen saturation, temperature); early-
onset infection (eg, positive blood or cerebrospinal fluid 
culture with a recognised pathogen recorded in the first 
3 days); treatment on day 1 (eg, infusion of inotropes, 
mechanical ventilation, and treatment with inhaled nitric 
oxide); and organisational factors (eg, postnatal transfer 
within 24 h, neonatal network of birth); further details can 
be found in the appendix (pp 2–5).
Analyses used the potential outcomes framework and 
propensity score method. We did 1:1 matching of babies 
that received no enteral feeds to babies who were fed 
enterally during therapeutic hypothermia. For each infant, 
the propensity of the nutritional exposure (enteral feeds or 
no enteral feeds) was estimated by logistical regression 
that included all background variables as covariates. 
Matched pairs were formed within these groups with 
one infant from either exposure group. Pairs were first 
matched by birth year (four 2 year bands) and arterial 
umbilical cord pH (three bands: <6·9, 6·9–7·0, and >7·0), 
making 12 groups in total. Matched pairs were then 
formed within propensity-score deciles defined separately 
for each background group. Because this matching pro-
cedure involves some randomness, it was replicated 
25 times to produce 25 matched cohorts. Every subsequent 
analysis was done separately for each matched cohort 
and the replicated results were averaged to reduce the 
effect of the uncertainty involved in matching. A detailed 
description of the matching process is provided in the 
appendix (pp 9–11). The success of the matching process 
is shown by standardised differences of the background 
variables across each group before and after matching 
(see appendix pp 12–13).18 Outcomes in the resulting 
two matched subgroups were then compared by methods 
identical to those for a randomised trial, with absolute and 
relative risks of serious adverse outcomes derived. The 
two-sample t test was used for all comparisons of matched 
groups. For the odds ratio, the SE was estimated as 
described by Morris and Gardner.19 The SE of the estimate 
of the treatment effect was obtained by combining the 
within-replication SE and between-replication SE.20 All 
p values are two-sided.
We imputed data for babies who had records with 
missing data about receipt of therapeutic hypothermia 
on the second day, but who were recorded as having 
received therapeutic hypothermia on both the preceding 
See Online for appendix
Articles
4 www.thelancet.com/child-adolescent   Published online April 20, 2021   https://doi.org/10.1016/S2352-4642(21)00026-2
and following days and did not die during cooling. No 
other data were imputed.
Two preplanned sensitivity analyses were done. First, 
analysis was restricted to babies born between Jan 1, 2012 
and Dec 31, 2017, in England and Wales, during which 
period all NHS neonatal units in these two countries 
contributed data to the NNRD. This analysis was done to 
determine whether using the less complete NNRD data 
submitted before Jan 1, 2012 introduces bias. Second, 
analysis was re stricted to infants for whom all enteral or 
parenteral feeding data have been actively recorded, by 
excluding infants with missing nutrition data during the 
first 4 days.
A third, post-hoc, sensitivity analysis was done (fol-
lowing the advice of the clinical investigator group and 
with the agreement of study steering committee) to 
examine the effect of nutritional practice on the first 
day as an additional background matching variable. 
In a final sensitivity analysis, receipt of parenteral 
nutrition on the first day after birth was added as a 
background variable to the propensity model. We ac-
counted for multiple testing by applying the Bonferroni 
correction.
Before comparative analysis of matched groups, it 
became clear that the proportion of missing data was 
high in 2008 and 2009. The protocol was therefore 
altered and analysis was restricted to babies born 
between Jan 1, 2010 and Dec 31, 2017, for all analyses. 
The study was overseen by an independent study 
steering committee, which approved all deviations from 
protocol. Analyses were done using SAS (version 9.3) 
and R (version 3.3.1).
Role of the funding source
This study was funded by the UK National Institute for 
Health Research (NIHR) Health Technology Assessment 
programme (16/79/13). The funder had no role in designing 
the study, the collection, analysis, or interpret ation of the 
data, or in the writing of this Article.
Results
Between Jan 1, 2010, and Dec 31, 2017, 703 907 babies were 
admitted to NHS neonatal units in England, Scotland, or 
Wales; 6030 were at least 36 weeks of gestational age and 
treated with therapeutic hypo thermia for 3 days or died 
during treatment. 1873 (31·1%) of 6030 received enteral 
feeds during therapeutic hypo thermia; this proportion 
changed only slightly between 2010 and 2017.
In the total study cohort of babies, and before 
matching, seven (0·1%) of 6030 babies that received 
thera peutic hypothermia were diagnosed with severe 
necrotising enterocolitis, and 68 (1·1%) of 6030 were 
classified as having necrotising enterocolitis using the 
pragmatic definition. 30 (0·5%) of 6030 babies had a 
pure growth of a recognised pathogen in a blood culture 
after day 3. Pragmatically defined late-onset infection 
was more common than pure growth (1559 [25·9%] 
of 6030). Breastfeeding at discharge was reported in 
2784 (46·2%) of 6030 babies and this proportion in-
creased during the study period. Among babies that 
suckled at the breast, the first breastfeed was at a median 
age of 7 days (IQR 6–9). Among babies that were fed 
maternal breastmilk (including by bottle or gastric tube), 
median age at first receiving maternal breastmilk was 
5 days (IQR 4–6). Survival to discharge was high 
(5444 [90·3%] of 6030). Median length of stay in the 
neonatal unit was 11 days (IQR 8–16). Most babies 
(5640 [93·5%] of 6030) had a central line placed, for a 
median duration of 5 days (IQR 3–6). 1208 (20·0%) of 
6030 babies had an episode of hypoglycaemia recorded 
during their neonatal stay. 
For comparative analyses, we formed a matched co-
hort of 3236 babies (1618 pairs; figure 1), and a good 
balance was achieved for all recorded background vari-
ables (table 1; appendix p 13). The incidence of severe 
necrotising enterocolitis was very low and comparative 
analyses were not done (table 2). After matching, prag-
matically defined necrotising enterocolitis incidence was 
lower among babies fed during therapeutic hypo thermia 
than in babies who were not fed (difference –0·5%, 
Figure 1: Participant flow for the primary analysis
For a definition of extreme propensity see the appendix (p 10). 
703 907 babies born between Jan 1, 2010, and Dec 31, 2017, and 
 admitted to neonatal units contributing to the National 
 Neonatal Research Database   
697 877 babies not eligible for 
 inclusion
6030 given therapeutic hypothermia 
 5887 babies with gestational age of 36 weeks or older 
  and who were given therapeutic hypothermia for 
  3 consecutive days or who died during that period  
 143 babies recorded as having received therapeutic 
  hypothermia on the first and third day but with 
  missing data about second day therapeutic 
  hypothermia status
  
183 excluded
 180 missing data for enteral
           nutrition for all days
       3 missing data for sex
5847 in comparative analysis cohort
2611 excluded
 2047 no matched pair found 
 419 extreme propensity 
  round 1 
 145 extreme propensity 
  round 2
3236 (1618 pairs) in enteral feeding matched cohort analysis 
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95% CI –1·0 to –0·1; p=0·028; table 3). The number 
of culture-positive late-onset infections was similar 
between groups; but pragmatically defined late-onset 
infection was less common in babies who were fed than 
not fed. Survival to discharge was higher in babies that 
were fed than were not fed; as was breastfeeding at 
discharge). Incidence was similar between groups for 
recorded hypoglycaemia and weight-for-gestational-
age SD score at discharge from neonatal unit. First 
breastfeed and first breastmilk feed were earlier in 
babies that were fed than unfed during therapeutic 
hypothermia. Length of neonatal unit stay, duration of 
Unmatched cohort Matched cohort
No enteral feeds (n=3975) Enterally fed (n=1872) No enteral feeds (n=1618) Enterally fed (n=1618)
Sex
Male 2173 (54·7%) 1055 (56·4%) 903 (55·8%) 903 (55·8%)
Female 1802 (45·3%) 817 (43·6%) 715 (44·2%) 715 (44·2%)
Gestational age at birth, weeks 39·3 (1·6) 39·5 (1·5) 39·5 (1·5) 39·5 (1·5)
Birthweight, g 3358 (621) 3395 (636) 3403 (635) 3386 (633)
Caesarean delivery 1921 (50·6%) 738 (41·2%) 649 (41·9%) 638 (41·2%)
Missing 178 80 70 68
Median maternal age, years 30 (26–34) 31 (27–35) 31 (27–35) 31 (27–35)
Maternal chorioamnionitis suspected 406 (12·6%) 240 (15·2%) 202 (15·1%) 187 (13·6%)
Missing 757 288 283 247
Maternal smoking during pregnancy 524 (15·4%) 191 (11·7%) 159 (11·3%) 169 (12·0%)
Missing 566 244 207 205
Maternal race or ethnicity
White 2598 (77·5%) 1185 (76·5%) 1041 (77·1%) 1040 (77·3%)
Asian or mixed Asian 399 (11·9%) 200 (12·9%) 174 (12·9%) 169 (12·6%)
Black or mixed black African 277 (8·3%) 120 (7·7%) 99 (7·3%) 103 (7·7%)
Other 80 (2·4%) 44 (2·8%) 36 (2·7%) 34 (2·5%)
Missing 621 323 268 272
Maternal diabetes* 171 (4·3%) 75 (4·0%) 66 (4·1%) 60 (3·7%)
Maternal deprivation score†
Decile 1 or 2 1017 (29·4%) 351 (21·0%) 334 (27·0%) 311 (21·6%)
Missing 515 204 379 374 
Primiparous* 2107 (53·0%) 991 (52·9%) 857 (53·0%) 844 (52·2%)
Umbilical cord arterial pH
<6·9 913 (32·4%) 420 (31·1%) 368 (31·6%) 368 (31·6%)
6·9–7·0 661 (23·5%) 318 (23·5%) 262 (22·5%) 262 (22·5%)
>7·0 1240 (44·1%) 613 (45·4%) 536 (46·0%) 536 (46·0%)
Missing 1161 521 452 452
Apgar score
0–1 695 (19·1%) 223 (12·8%) 231 (15·2%) 198 (13·1%)
2–4 1476 (40·6%) 736 (42·1%) 650 (42·8%) 648 (42·8%)
5–7 1140 (31·4%) 623 (35·6%) 490 (32·3%) 537 (35·4%)
8–10 324 (8·9%) 166 (9·5%) 147 (9·7%) 132 (8·7%)
Missing 340 124 100 103 
Received chest compressions at resuscitation* 1555 (39·1%) 608 (32·5%) 560 (34·6%) 532 (32·9%)
Intubated at resuscitation* 2619 (65·9%) 1126 (60·1%) 1020 (63·0%) 995 (61·5%)
Mechanical ventilation on day of admission 3176 (83·1%) 1335 (73·4%) 1196 (77·6%) 1189 (75·3%)
Missing 155 53 76 40 
Treatment with inotropes on day of admission 1099 (29·0%) 320 (17·9%) 295 (19·3%) 288 (18·5%)
Missing 180 80 90 63 
Early onset, culture-positive blood infection* 44 (1·1%) 11 (0·6%) 26 (1·0%) 11 (0·7%)
Data are n (%), mean (SD), or median (IQR). *Data were collected via ticking a box to indicate the presence of each condition and it is not possible to distinguish between 
missing data and a negative answer for boxes left empty. †Maternal deprivation was calculated using the index of multiple deprivation decile based on the UK Office for 
National Statistics Lower-layer Super Output Area of the maternal residence. 
Table 1: Background variables by feeding group for unmatched and matched cohorts of babies receiving therapeutic hypothermia 
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parenteral nutrition, and days with a central line in situ 
were all lower in babies who were fed than unfed 
(tables 2–3). These findings were robust to sensitivity 
analyses detailed in the appendix (p 14). If enteral feeds 
were given during therapeutic hypo thermia, these were 
most commonly maternal breastmilk (figure 2).
Discussion
In this large, population-based cohort of term and near-
term infants treated with therapeutic hypothermia, 
we identified variation in nutritional practice, with 
sizable minorities of babies receiving milk feeds during 
hypo thermia. We showed that severe necrotising entero-
colitis (using a robust and validated definition) is rare in 
this popu lation, with an incidence of approxi mately one 
per 1000 babies. Late-onset culture-positive bloodstream 
infection is also rare, occurring in approximately five per 
1000 infants, although treatment for presumed infection 
is common.
Almost one in three babies who receive therapeutic 
hypothermia in NHS neonatal units are fed during hypo-
thermia, predominantly with maternal breastmilk. Necro-
tising enterocolitis is rare in these babies, and after 
matching for an extensive list of background characteristics, 
Unmatched cohort Matched cohort








Severe necrotising enterocolitis (confirmed at surgery, 
post mortem, or recorded on death certificate) 
<5 <5 <5 <5
Necrotising enterocolitis (pragmatic definition) 54 (1·4%) 11 (0·6%) 18 (1·1%) 9 (0·6%)
Late-onset, blood culture-positive infection 25 (0·6%) 5 (0·3%) 8 (0·5%) <5
Late-onset infection (pragmatic definition) 1193 (30·0%) 321 (17·1%) 460 (28·4%) 271 (16·8%)
Survival at discharge 3498 (88·1%) 1794 (95·9%) 1465 (90·6%) 1552 (96·0%)
Hypoglycaemia 846 (21·3%) 316 (16·9%) 293 (18·1%) 269 (16·6%)
Onset of breastfeeding, days* 7 (6–10) 6 (5–8) 7 (6–9) 6 (5–8)
Breastfeeding at discharge* 1690 (42·5%) 1029 (55·0%) 752 (46·5%) 883 (54·6%)
Time to first maternal milk, days† 5 (5–6) 3 (2–4) 5 (5–6) 3 (2–4)
Received parenteral nutrition 1689 (42·5%) 683 (36·5%) 674 (41·6%) 596 (36·8%)
Duration of parenteral nutrition, days 3 (2–5) 3 (2–3) 3 (2–5) 3 (2–3)
Had a central venous line 3832 (96·4%) 1637 (87·4%) 1546 (95·5%) 1417 (87·6%)
Central venous line in situ, days 5 (4–7) 4 (3–5) 5 (4–6) 4 (3–5)
Weight Z score at discharge –0·7 (–1·5 to 0·1) –0·6 (–1·3 to 0·2) –0·6 (–1·4 to 0·2) –0·7 (–1·4 to 0·1)
Length of stay, days 11 (8–17) 10 (7–13) 11 (8–16) 10 (7–13)
Data are n (%) or median (IQR). *Breastfeeding refers to suckling at the breast and does not include babies that received expressed breastmilk by bottle. †First maternal milk 
includes receipt of maternal breastmilk by bottle. 
Table 2: Outcomes by feeding group for unmatched and matched cohorts of babies receiving therapeutic hypothermia 




Difference between groups Estimated odds ratio p value
Necrotising enterocolitis (pragmatic definition) 1·1% (0·7–1·4) 0·5% (0·2–0·9) –0·5% (–1·0 to –0·1) 0·50 (0·22–1·12) 0·028
Late-onset infection (National Neonatal Audit Programme definition) 0·5% (0·2–0·7) 0·3% (0·04–0·4) –0·2% (–0·5 to 0·1) 0·55 (0·17–1·80) 0·19
Late-onset infection (pragmatic definition) 28·4% (26·7–30·0) 16·7% (15·0–184) –11·6% (–14·0 to –9·3) 0·51 (0·43–0·60) <0·0001*
Hypoglycaemia 18·1% (16·7–19·5) 16·6% (15·0–18·3) –1·5% (–3·7 to 0·6) 0·90 (0·75–1·08) 0·17
Survival at discharge 90·8% (89·7–91·8) 96·0% (95·0–96·8) 5·2% (3·9–6·6) 2·42 (1·80–3·26) <0·0001*
Breastfeeding at discharge 46·7% (44·8–48·5) 54·6% (52·4–56·8) 8·0% (5·1–10·8) 1·38 (1·20–1·58) <0·0001*
Length of stay, days 14·8 (14·2–15·5) 12·7 (12·0–13·3) –2·2 (–3·0 to –1·2) NA <0·0001*
Onset of breastfeeding, days† 8·7 (8·4–9·0) 7·3 (6·9–7·7) –1·4 (–1·9 to –0·9) NA <0·0001*
First maternal milk, days‡ 5·4 (5·4–5·5) 3·3 (3·2–3·4) –2·1 (–2·2 to –2·0) NA <0·0001*
Duration of parenteral nutrition, days 3·7 (3·5–3·8) 3·0 (2·7–3·4) –0·7 (–1·1 to –0·2) NA 0·0018*
Duration of central venous line, days 5·5 (5·3–5·7) 4·3 (4·1–4·5) –1·2 (–1·5 to –0·9) NA <0·0001*
Weight-for-gestational-age SD score at discharge from neonatal unit –0·60 (–0·65 to –0·55) –0·54 (–0·59 to –0·48) 0·06 (–0·01 to –0·13) NA 0·11
Data are estimated odds ratio (95% CI). Results were averaged over the 25 replications of the matching procedure. *Outcome measure remains statistically significant after accounting for multiple testing using 
the Bonferroni correction. NA=odds ratio could not be estimated for continuous data. †Breastfeeding refers to suckling at the breast and does not include babies that received expressed breastmilk by bottle. 
‡First maternal milk includes receipt of maternal breastmilk by bottle.
Table 3: Outcomes for babies fed enterally versus not fed enterally during therapeutic hypothermia 
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pragmatically defined necrotising entero colitis was diag-
nosed less frequently in babies fed during therapeutic 
hypothermia than in babies who were unfed. Milk feeding 
during therapeutic hypothermia was also associated with 
other beneficial outcomes, including shorter length of 
neonatal unit stay, higher incidence of breastfeeding, and a 
lower incidence of suspected infection, all after matching 
for multiple potential confounding factors.
To our knowledge, this study assesses the largest and 
most comprehensive cohort of babies who have received 
therapeutic hypothermia. Necro tising enterocolitis is 
well described in case studies and single-centre series 
in babies with hypoxic is chaemic encephal opathy;21,22 
however, there has been a paucity of robust incidence 
data. By applying a vali dated definition of severe 
necrotising enterocolitis with confirmation of cases to 
large-scale population data,23 we have for the first time 
produced robust incidence rates for necro tising entero-
colitis in babies receiving therapeutic hypo thermia. 
Our finding that enteral feeding during therapeutic 
hypothermia is safe and might be associated with 
benefit is supported by the few data from previous 
studies. A small, retro spective case-control study5 of 
34 infants compared minimal enteral nutrition with 
withholding feeds during therapeutic hypothermia, and 
found that duration of parenteral nutrition and hospital 
stay were lower in the enteral feeding group, although 
the study did not adjust for illness severity, which 
differed between groups. Another small retrospective 
study compared 34 babies cared for in the UK, which 
commonly withheld feeds, versus 51 babies cared for 
in Sweden, which commonly initiated feeds during 
hypothermia.6 In keeping with our data, the study 
found no complications in either group and a higher 
proportion of babies breastfeeding at discharge among 
the babies in Sweden. Our study adds considerably 
to the existing literature through the large, population-
level nature of the cohort and by application of 
statistically robust approaches to deal with potential 
confounding in comparative analyses.
We aimed to identify optimal approaches to nutrition 
during therapeutic hypothermia, through comparative 
analyses of babies fed milk and those not fed milk. 
Although we did not undertake a randomised trial, we 
applied multiple approaches to reduce bias. We used a 
comprehensive range of background data items to form 
matched groups, balanced on all measured potential con-
founders. We followed a detailed, preregistered protocol 
that specified exposures, background factors, outcomes 
and the data items used to define outcomes, and the 
matching process.14 Also, the use of routinely recorded 
data reduced the risk of ascertainment bias because data 
collection occurred far in advance of study conception. 
Furthermore, we applied sensitivity analyses to see 
whether data quality and definitions of the nutritional 
exposures influenced results. By using existing data, 
we were able to include a large number of infants and 
to examine even rare outcomes, such as pragmatically 
defined necrotising enterocolitis and culture-positive 
bloodstream infection; the sample size was several times 
larger than all previous randomised trials of therapeutic 
hypothermia combined. 
The most important limitation of this study stems from 
the non-randomised study design used; the matched 
approach that was applied was only able to account for 
measured confounders. Although we used a wide range 
of background and day 1 clinical data items to form 
matched groups, and the statistical measures of balance 
indicated that an acceptable balance had been obtained, 
we cannot exclude the chance that factors might have 
differed by small but clinically relevant degrees between 
the groups, or that there were important differences in 
unmeasured factors between the comparator groups. 
In matched ana lyses, we found higher survival to neonatal 
unit discharge in babies that were fed than were unfed 
during therapeutic hypothermia; this difference in sur-
vival is unlikely to be caused by enteral feeding during 
therapeutic hypo thermia and suggests that residual con-
founding is present in the enteral comparison. Further-
more, there might be other additional markers of sickness 
that are discernible to clinicians and which influence 
decision making regarding enteral feeding, but which 
are not captured, even in the extensive data items held in 
the NNRD. Such residual and unmeasured confounding 
by indication might overestimate the benefit associated 
with enteral feeding, and results should be interpreted 
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Figure 2: Types of milk used for enteral feeding during therapeutic hypothermia 
Articles
8 www.thelancet.com/child-adolescent   Published online April 20, 2021   https://doi.org/10.1016/S2352-4642(21)00026-2
than planned number of infant pairs; however, the 
matched groups were still considerably larger than previ-
ous trials and had power to detect small but clinically 
relevant differences of 1·0% in necrotising enterocolitis. 
Although we had broad parent involvement in the 
selection of outcomes for this study, we were limited 
(by the data source used) to short-term outcomes, which 
might not completely reflect the outcomes of greatest 
importance to parents and patients.13 As with any study 
that uses routinely recorded data, data completeness and 
accuracy are dependent on the health-care professionals 
who enter the data, and might vary between sites. Specifi-
cally, data describing daily volume of feeds are highly 
incomplete, therefore we were unable to describe how 
much enteral feed was given or how quickly feeds were 
increased. Furthermore, culture-positive blood stream in-
fection is likely to be under-reported in systems such 
as the NNRD that use routinely recorded UK neonatal 
clinical data,17 hence our a-priori analysis used a pragmatic 
definition of late-onset infection. The NNRD is formed 
from data entered as part of a baby’s clinical care record; 
these data are used for multiple purposes including 
national audits, funding, and staffing, and data held in 
the NNRD have been validated against independent 
clinical trial data.11
Overall, necrotising enterocolitis is rare in term and 
near-term babies receiving therapeutic hypothermia 
and might be less common in babies who were fed 
during therapeutic hypothermia. The introduction of 
enteral feeds in term and near-term babies during 
therapeutic hypothermia appears to be safe and might 
be associated with benefits, including a higher pro-
portion of babies breastfeeding at discharge, and shorter 
length of neonatal unit stay.
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